Seeking Alpha
Monday, July 13 2009  |  06:13 EDT  | 
DJIA (DIA) S&P 500 (SPY)
News & Data
Market Currents
Top Stories
Summary
Conference
Calendar
Thursday, January 8, 2009 7:26 AM TweetThis
  • Wyeth (WYE) is in talks to buy Dutch vaccine maker Crucell (CRXL), part of its efforts to gain market share in one of the fastest growing parts of the industry. Sources say a deal valuing Crucell at over €1B ($1.35B) could be reached as early as next week.